Bioethicist Raju Kucherlapati answers questions about the Precision Medicine Initiative
Predicting and examining which mutations in a cardiomyopathy gene are benign and which ones are harmful.
Robert C. Green, MD, MPH, of the BWH Division of Genetics, with colleagues from the Laboratory of Molecular Medicine, operated by Partners HealthCare Personalized Medicine and led by Heidi Rehm, PhD, have developed a reporting approach to effectively return the results of whole-genome screening to physicians in a concise report featuring a single-page summary. They describe their approach in a new BMC Medical Genetics. Find out more about their work. Read more.]
Partners HealthCare Biobank introduces electronic consent.
A research team led by Karen Cichowski, PhD, and Thomas DeRaedt, PhD, BWH Division of Genetics,…
A study led by Lisa Lehmann, MD, PhD, director of Bioethics, BWH Department of Medicine, reveals that…
The Partners HealthCare Biobank is poised to accelerate medical research and cut the cost of health care across the Partners system.
The new center is seeing patients with suspected genetic disease in need of evaluation and diagnostic testing.
Researchers have transitioned Profile®, one of the nation’s most comprehensive personalized medicine initiatives in cancer.
Fill in your details below or click an icon to log in:
You are commenting using your WordPress.com account. ( Log Out / Change )
You are commenting using your Twitter account. ( Log Out / Change )
You are commenting using your Facebook account. ( Log Out / Change )
You are commenting using your Google+ account. ( Log Out / Change )
Connecting to %s
Notify me of new comments via email.
Notify me of new posts via email.
Basic HTML is allowed. Your email address will not be published.
Subscribe to this comment feed via RSS